You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Last Updated: May 26, 2020

DrugPatentWatch Database Preview

Hikma Farmaceutica Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?

HIKMA FARMACEUTICA has forty approved drugs.

Summary for Hikma Farmaceutica
US Patents:0

Drugs and US Patents for Hikma Farmaceutica

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER fluconazole INJECTABLE;INJECTION 078764-002 Jan 30, 2012 DISCN No No   Start Trial   Start Trial
Hikma Farmaceutica IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 091032-001 Dec 20, 2010 AP RX No No   Start Trial   Start Trial
Hikma Farmaceutica FLUCONAZOLE IN SODIUM CHLORIDE 0.9% fluconazole INJECTABLE;INJECTION 076736-001 Aug 23, 2005 AP RX No No   Start Trial   Start Trial
Hikma Farmaceutica GLYCOPYRROLATE glycopyrrolate INJECTABLE;INJECTION 090963-001 Sep 21, 2011 AP RX No Yes   Start Trial   Start Trial
Hikma Farmaceutica DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 202651-001 Aug 9, 2012 AP RX No No   Start Trial   Start Trial
Hikma Farmaceutica CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065342-004 Jan 10, 2008 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.